BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5108862)

  • 1. [Influence of various oral contraceptives on hormone secretion of the hypophysis and ovary in the sexually mature female].
    Schmidt-Elmendorff H; Kaiser E
    Arch Gynakol; 1971 Jun; 211(1):233-4. PubMed ID: 5108862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ovulation inhibitors and ACTH reserve].
    Rindt W; Heinen G; Oertel GW
    Endokrinologie; 1971 Apr; 57(3):358-63. PubMed ID: 4325995
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and follicle-stimulating hormone.
    Schmidt-Elmendorff H; Kopera H
    Lancet; 1968 Jun; 1(7553):1194-5. PubMed ID: 4172299
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormone excretion during and after treatment with Lyndiol 2.5].
    Keller M
    Gynaecologia; 1967; 163(4):187-98. PubMed ID: 6029674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action duration of lynestrenol as a component of an anticontraceptive agent].
    Schmidt-Elmendorff H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):352-5. PubMed ID: 5148892
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
    Elstein M; Briston PG; Jenkins M; Kirk D; Miller H
    Br Med J; 1974 Jan; 1(5896):11-3. PubMed ID: 4808812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ovarian response to gonadotrophins after administration of an oral contraceptive.
    Pujol-Amat P; Urgell-Roca JM; Mároquez-Ramirez M
    J Obstet Gynaecol Br Commonw; 1971 Mar; 78(3):261-5. PubMed ID: 5558842
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modus of hormonal excretion and hormonal effects of 1-alpha-methyl-5-alpha-androsten-17-beta-ol-3-on (mesterolon in women)].
    Abrahamsson L; Haagenrud A; Hackl H; Haglund V; Wassén A
    Arch Gynakol; 1973 Jun; 215(2):157-69. PubMed ID: 4740965
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the long term administration of oral contraceptives on excretion values for follicle-stimulating hormone and luteinising hormone.
    Bell ET; Herbst AL; Krishnamurti M; Loraine JA; Mears E; Jackson MC; Garcia CR
    Acta Endocrinol (Copenh); 1967 Jan; 54(1):96-104. PubMed ID: 6071215
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle.
    Schmidt-Elmendorff H; Kaiser E; Kopera H
    Arzneimittelforschung; 1969 Aug; 19(8):1277-9. PubMed ID: 5820293
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the site of action of oral contraceptive steroids. II. Plasma LH and FSH levels after administration of antifertility steroids and LH-releasing hormone(LH-RH).
    Schally AV; Parlow AF; Carter WH; Saito M; Bowers CY; Arimura A
    Endocrinology; 1970 Mar; 86(3):530-41. PubMed ID: 4188612
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
    Starup J; Lebech PE
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic patterns of gonadotrophin, pregnanediol, and corticoid excretion in women on long-term oral contraceptive therapy.
    Roland M; Paulson SR; Knudsen KA; Laurie RE; Edgren RA
    Fertil Steril; 1971 Jul; 22(7):416-23. PubMed ID: 5556748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Excretion of gonadotropins and estrogens in dysfunctional uterine hemorrhages].
    Sokolov EG; Savchenko ON
    Probl Endokrinol (Mosk); 1968; 14(5):8-12. PubMed ID: 5736239
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of suppression of menstruation with ethynodiol diacetate upon the pituitary, ovary, and endometrium.
    Flowers CE; Vorys N; Stevens V; Miller AT; Jensen L
    Am J Obstet Gynecol; 1966 Nov; 96(6):784-803. PubMed ID: 5927291
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and laboratory experience with a modified low dosage sequential oral contraceptive.
    Wamsteker EF
    Int J Fertil; 1968; 13(4):436-43. PubMed ID: 5700403
    [No Abstract]   [Full Text] [Related]  

  • 20. [Suppression of the endocrine activity of the ovaries].
    Jayle MF
    Rev Fr Endocrinol Clin; 1967; 8(5):407-15. PubMed ID: 4230393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.